About This Video
Sunshine Heart Announces First U.S. C-Pulse Implants.
Sunshine Heart (ASX: SHC), a global medical device company focused on innovative heart assist technologies, announced today that The Ohio State University Medical Center in Columbus, Ohio has successfully completed the first two implants of the Company's C-Pulse™ heart assist system under a 20 person clinical trial approved by the U.S. Food and Drug Administration (FDA).
To view Multimedia News Release, go to http://www.prnewswire.com/mnr/sunshineheart/37917/
This website uses Adobe® Flash™ Player 9
Download Flash Now
If you are using Internet Explorer, you will need to restart your browser
after installing Flash.
Adobe and Flash are registered trademarks of Adobe Systems incorporated.
All rights reserved.